MOTT DAVID M 1219871 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-08 | 4 | Mott David M | DIRECTOR | holding | 9595.0 | 0 | 0.84 | 0.0 | See Note 3 | Common Stock | MERSANA THERAPEUTICS, INC. | NA | 114.39 (MRSN) | ||
| 2023-06-12 | 2023-06-08 | 2023-06-08 | 4 | Mott David M | DIRECTOR | acq | 14467.0 | 2.59 | 1.26 | 0.0 | Direct | Common Stock | MERSANA THERAPEUTICS, INC. | code A | 557932.0 | 114.39 (MRSN) |
| 2023-06-13 | 2023-06-10 | 2023-06-10 | 4 | Mott David M | DIRECTOR | acq | 3100.0 | 7.08 | 0.36 | 0.0 | Direct | Common Stock | NOVAVAX INC | code M | 43800.0 | 86.31 (NVAX) |
| 2023-06-16 | 2023-06-15 | 2023-06-15 | 4 | Mott David M | DIRECTOR | acq | 25510.0 | 2.14 | 1.19 | 0.0 | Direct | Common Stock | ARDELYX, INC. | code A | 1192275.0 | 214.46 (ARDX) |
| 2023-10-04 | 2023-10-02 | 4 | Mott David M | DIRECTOR | holding | 9595.0 | 0 | 0.8 | 0.0 | See Note 2 | Common Stock | MERSANA THERAPEUTICS, INC. | NA | 120.51 (MRSN) | ||
| 2023-10-04 | 2023-10-02 | 2023-10-02 | 4 | Mott David M | DIRECTOR | acq | 15873.0 | 2.74 | 1.32 | 0.0 | Direct | Common Stock | MERSANA THERAPEUTICS, INC. | code A | 579884.0 | 120.51 (MRSN) |
| 2024-01-04 | 2024-01-02 | 4 | Mott David M | DIRECTOR | holding | 9595.0 | 0 | 0.8 | 0.0 | See Note 2 | Common Stock | MERSANA THERAPEUTICS, INC. | NA | 120.58 (MRSN) | ||
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Mott David M | DIRECTOR | acq | 8810.0 | 1.5 | 0.73 | 0.0 | Direct | Common Stock | MERSANA THERAPEUTICS, INC. | code A | 588694.0 | 120.58 (MRSN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-08 | 2023-06-08 | 4 | Mott David M | DIRECTOR | acq | 18355.0 | 100.0 | 1.6 | 8.64 | Direct | Stock Option (Right To Buy) | MERSANA THERAPEUTICS, INC. | code A | 18355.0 | 114.39 (MRSN) |
| 2023-06-13 | 2023-06-10 | 2023-06-12 | 4 | Mott David M | DIRECTOR | acq | 7710.0 | 100.0 | 0.89 | 7.78 | Direct | Stock Option (Right To Buy) | NOVAVAX INC | code A | 7710.0 | 86.31 (NVAX) |
| 2023-06-13 | 2023-06-10 | 2023-06-12 | 4 | Mott David M | DIRECTOR | acq | 6670.0 | 100.0 | 0.77 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code A | 6670.0 | 86.31 (NVAX) |
| 2023-06-13 | 2023-06-10 | 2023-06-10 | 4 | Mott David M | DIRECTOR | dsp | 3100.0 | 100.0 | 0.36 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 0.0 | 86.31 (NVAX) |
| 2023-06-16 | 2023-06-15 | 2023-06-15 | 4 | Mott David M | DIRECTOR | acq | 49237.0 | 100.0 | 2.3 | 3.92 | Direct | Stock Option (Right To Buy) | ARDELYX, INC. | code A | 49237.0 | 214.46 (ARDX) |
| 2023-07-03 | 2023-07-03 | 2023-07-03 | 4 | Mott David M | DIRECTOR | acq | 1462927.0 | 100.0 | 14.71 | 0.16 | Direct | Option To Purchase Ordinary Shares | ADAPTIMMUNE THERAPEUTICS PLC | code A | 1462927.0 | 994.21 (ADAP) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)